1.
COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA. Mediterr J Hematol Infect Dis [Internet]. 2021 Apr. 29 [cited 2026 Apr. 18];13(1):Page e2021034. Available from: https://www.mjhid.org/mjhid/article/view/4555